Thomas Needham
InvestorInvestor at Broadview Ventures · Board director at Basking Biosciences
Boston, Massachusetts
Writes $100K – $5M checks · typically $1.5M
About
Managing Director leading Broadview's Biopharmaceuticals practice and overseeing investment strategy and portfolio management; also Managing Director of Longview Ventures. Brings 30 years in life-science venture investing and executive roles, previously at Merrimack, C4 Therapeutics, Synthesis Capital, and Advent International.
Contact· self-published, not guessed
Likely email· guessed from name + firm domain, not firm-published
- t•••@broadviewventures.orgreveal100% confident
Board director at Basking Biosciences
Intro paths
→
In turn, Thomas can intro founders to Basking Biosciences's investors below.
Basking Biosciences's investors · 6
Co-founders at Basking Biosciences
SN
Shahid NimjeeCo-founder, Chief Scientific Officer and Stroke Clinical Lead
BS
Bruce SullengerCo-founder
Experience
- Broadview Ventures IncManaging Directorcurrent2026 — presentBoston, MA
- Broadview Ventures IncDirector, Head of BioPharma2018 — 2026Boston, MA
- Longview VenturesManaging Directorcurrent2025 — presentBoston, MA
- Longview VenturesDirector, Head of BioPharma2019 — 2025
- Mosanna TherapeuticsBoard Observercurrent2025 — present
- Alveron PharmaBoard Observercurrent2024 — present
- Isomab LtdBoard of Directors, Membercurrent2024 — presentNottingham, England
- Basking Biosciences IncBoard of Directors, Membercurrent2023 — present
- Basking Biosciences IncChairman, Board of Directors2020 — 2023
- Comanche BiopharmaBoard Observercurrent2021 — presentConcord, MA
- HAYA TherapeuticsBoard Observercurrent2020 — presentLausanne, Vaud, Switzerland
- Antag TherapeuticsBoard Observer2023 — 2024Copenagen, Denmark
- Antag TherapeuticsBoard of Directors, Member2020 — 2023Copenhagen, Denmark
- RenovacorBoard of Directors, Member2021 — 2022Philadelphia, PA
- RenovacorChairman, Board of Directors2019 — 2021Philadelphia, PA
- Kantum BioBoard of Directors, Member2021 — 2022Boston, MA
- Kantum BioBoard Observer2018 — 2021Boston, MA
- NIDOBoard Observer2018 — 2019Needham, MA
- MerrimackChief Business Officer2017 — 2018Greater Boston
- C4 Therapeutics, Inc.Senior Vice President, Business Development2016 — 2017Greater Boston
- Synthesis CapitalManaging Director2007 — 2016Greater Boston
- Advent InternationalPrincipal2002 — 2007Greater Boston
- GPC BiotechVice President, Business Development2000 — 2002
- Mitotix, Inc.Vice President, Business Development1994 — 2000
Skills & more
Management3Strategy3Strategic Planning2Business Development13Corporate Development3Lifesciences7Biotechnology17Angel Investing1M&A experience1Healthcare3Acquisition Integration1Venture Capital26
+12 more
Clinical DevelopmentCorporate FinanceMergers & AcquisitionsBiopharmaceuticalsLicensingDue DiligenceTechnology TransferAsset ManagmentCommercializationDrug DiscoveryBusiness StrategyPharmaceutical IndustryFrom Thomas's professional profile.
Colleagues at Broadview Ventures
Annabel Chen-Tournoux
Investor at Broadview Ventures
Anubodh Sunny Varshney
Venture Advisor at Broadview Ventures
Benjamin Kreitman
Principal at Broadview Ventures
Christopher Colecchi
Managing Director at Broadview Ventures
Christopher de Souza
Director at Broadview Ventures
Daniel Gottlieb
Director at Broadview Ventures
David Milan
Chief Scientific Officer, Leducq Corp at Broadview Ventures
David Prim
Principal at Broadview Ventures
Network5
Benjamin Kreitman
Principal at Broadview Ventures
Christopher Colecchi
Managing Director at Broadview Ventures
Daniel Gottlieb
Director at Broadview Ventures
David Prim
Principal at Broadview Ventures
Maria Berkman
Partner at Vensana Capital
Investors connected to Thomas in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Thomas Needham?
- Managing Director leading Broadview's Biopharmaceuticals practice and overseeing investment strategy and portfolio management; also Managing Director of Longview Ventures. Brings 30 years in life-science venture investing and executive roles, previously at Merrimack, C4 Therapeutics, Synthesis Capital, and Advent International.
- Where does Thomas Needham work?
- Thomas Needham is Investor at Broadview Ventures and Board director at Basking Biosciences.
- What check size does Thomas Needham write?
- Thomas Needham typically writes checks of $100K – $5M.
- Where did Thomas Needham go to school?
- Thomas Needham studied at Babson F.W. Olin Graduate School of Business (MBA, Highest Distinction); Bowdoin College (AB, cum laude).
Same school
Also attended Babson F.W. Olin Graduate School of Business79
Jeff DoranInvestor at Spark CapitalPierre-Eric LeiboviciInvestor at DaphniKevin MunnellyInvestor at Third Rock VenturesBrian DixonManaging Partner at Kapor CapitalMurat BicerGeneral Partner at CRV (Charles River Ventures)Jess LynchGeneral Partner at FoundersEdge
+ 73 more
Also attended Bowdoin College55
Reed HastingsCo-founder of NetflixHolly MaloneyInvestment Team at General CatalystKen ChenaultInvestment Team at General CatalystKevin MunnellyInvestor at Third Rock VenturesEmily PawlakVice President at Volition CapitalJohn HarthorneFounder & Managing Director at Two Lanterns Venture Partners
+ 49 more
